Related Experiment Video
Updated: May 15, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Should we change the target blood pressure in diabetic patients?
1The Chaim Sheba Medical Center, affiliated to Sackler School of Medicine, Tel-Aviv University, Tel-Hashomer, Israel.
Insights
Lowering blood pressure (BP) in diabetic patients to near 130/80 mmHg offers stroke protection but may increase adverse effects. Balancing these factors is key for optimal cardiovascular risk management in diabetes.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Hypertension is a critical risk factor for cardiovascular disease in diabetic individuals.
- Current guidelines suggest a blood pressure (BP) target below 130/80 mmHg for patients with diabetes.
- Previous studies supporting intensive BP control achieved levels higher than the recommended target.
Purpose of the Study:
- To re-evaluate the benefits and risks of intensive blood pressure control in diabetic patients.
- To determine the optimal BP target for diabetic patients considering cardiovascular outcomes and adverse effects.
- To analyze the impact of intensive BP control on mortality, stroke, and other micro/macrovascular complications.
Main Methods:
- Review and re-analysis of earlier studies on BP control in diabetes.
- Examination of recently accumulated data regarding intensive BP management.
- Comparative analysis of outcomes associated with different BP control levels.
Main Results:
- Intensive BP control significantly reduces all-cause mortality and stroke rates.
- No significant benefits were observed for other microvascular or macrovascular outcomes (cardiac, renal, retinal).
- Lowering BP to less than 130/80 mmHg is linked to an increased risk of serious adverse events.
Conclusions:
- The optimal BP target in diabetic patients requires balancing cerebrovascular protection against increased risks of adverse effects.
- Intensive BP control may not benefit all microvascular or macrovascular outcomes in diabetes.
- A BP target close to 130/80 mmHg appears to be a reasonable goal for managing hypertension in diabetic patients.
Abstract:
Hypertension is a major modifiable risk factor for cardiovascular morbidity and mortality in diabetic patients. Guidelines recommend lowering blood pressure (BP) to less than 130/80 mmHg in diabetic patients. These recommendations are based on several studies in diabetic patients that showed the benefit of intensive BP control. However in all the studies the achieved BP was higher than 130/80 mmHg. Re-evaluation of earlier studies, as well as more recently accumulated data suggest that intensive BP control is associated with a significant reduction in all-cause mortality and stroke rate, but with no benefit for other microvascular or macrovascular (cardiac, renal and retinal) outcomes. Intensive BP control is associated with an increased risk of serious adverse effects, particularly for systolic BPs levels lower than 130 mmHg. When determining the target BP in diabetic patients one should balance the potential cerebrovascular protection against the increased risk of serious side effects, and the absence of benefit for other circulatory system. It seems therefore, that lowering BP to levels close to 130/80 mmHg should be the main goal of treatment in diabetic patients.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension V: Nursing Management
Diabetic Nephropathy
Errors occurring during blood pressure monitoring
Several factors...
Hypertension I: Introduction
